• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Guidewire Software Set to Join S&P MidCap 400; Arrowhead Pharmaceuticals to Join S&P SmallCap 600

    1/22/25 5:54:00 PM ET
    $APO
    $ARWR
    $B
    $GWRE
    Investment Managers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $APO alert in real time by email

    NEW YORK, Jan. 22, 2025 /PRNewswire/ -- Guidewire Software Inc. (NYSE:GWRE) will replace Arrowhead Pharmaceuticals Inc. (NASD: ARWR) in the S&P MidCap 400, and Arrowhead Pharmaceuticals will replace Barnes Group Inc. (NYSE:B) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, January 27. S&P 500 constituent Apollo Global Management Inc. (NYSE:APO) is acquiring Barnes Group in a deal expected to be completed soon pending final conditions.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    January 27, 2025

    S&P MidCap 400

    Addition

    Guidewire Software

    GWRE

    Information Technology

    January 27, 2025

    S&P MidCap 400

    Deletion

    Arrowhead Pharmaceuticals

    ARWR

    Health Care

    January 27, 2025

    S&P SmallCap 600

    Addition

    Arrowhead Pharmaceuticals

    ARWR

    Health Care

    January 27, 2025

    S&P SmallCap 600

    Deletion

    Barnes Group

    B

    Industrials

    For more information about S&P Dow Jones Indices, please visit www.spdji.com 

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com. 

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected] 

    Media Inquiries

    [email protected] 

    Cision View original content:https://www.prnewswire.com/news-releases/guidewire-software-set-to-join-sp-midcap-400-arrowhead-pharmaceuticals-to-join-sp-smallcap-600-302357962.html

    SOURCE S&P Dow Jones Indices

    Get the next $APO alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $APO
    $ARWR
    $B
    $GWRE

    CompanyDatePrice TargetRatingAnalyst
    Guidewire Software Inc.
    $GWRE
    5/22/2025$226.00Buy → Neutral
    DA Davidson
    Apollo Global Management Inc. (New)
    $APO
    4/10/2025$173.00Strong Buy
    Raymond James
    S&P Global Inc.
    $SPGI
    4/10/2025$600.00Buy
    BofA Securities
    S&P Global Inc.
    $SPGI
    3/12/2025$599.00Outperform
    Mizuho
    Guidewire Software Inc.
    $GWRE
    1/23/2025$210.00Buy
    Goldman
    S&P Global Inc.
    $SPGI
    12/20/2024$600.00Buy
    Citigroup
    Apollo Global Management Inc. (New)
    $APO
    11/19/2024$188.00Overweight
    Piper Sandler
    S&P Global Inc.
    $SPGI
    10/2/2024$599.00Outperform
    Evercore ISI
    More analyst ratings

    $APO
    $ARWR
    $B
    $GWRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Rosenbaum Michael George sold $311,234 worth of shares (1,400 units at $222.31), decreasing direct ownership by 0.60% to 231,668 units (SEC Form 4)

      4 - Guidewire Software, Inc. (0001528396) (Issuer)

      7/21/25 7:49:55 PM ET
      $GWRE
      Computer Software: Prepackaged Software
      Technology
    • Chief Executive Officer Rosenbaum Michael George sold $308,910 worth of shares (1,400 units at $220.65), decreasing direct ownership by 0.60% to 233,068 units (SEC Form 4)

      4 - Guidewire Software, Inc. (0001528396) (Issuer)

      7/15/25 6:31:40 PM ET
      $GWRE
      Computer Software: Prepackaged Software
      Technology
    • Chief Admin Officer, Gen Couns King James Winston sold $547,653 worth of shares (2,482 units at $220.65), decreasing direct ownership by 6% to 37,441 units (SEC Form 4)

      4 - Guidewire Software, Inc. (0001528396) (Issuer)

      7/15/25 6:29:57 PM ET
      $GWRE
      Computer Software: Prepackaged Software
      Technology

    $APO
    $ARWR
    $B
    $GWRE
    SEC Filings

    See more
    • SEC Form 11-K filed by S&P Global Inc.

      11-K - S&P Global Inc. (0000064040) (Filer)

      6/25/25 6:16:08 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • SEC Form 144 filed by Guidewire Software Inc.

      144 - Guidewire Software, Inc. (0001528396) (Subject)

      6/25/25 10:20:54 AM ET
      $GWRE
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 144 filed by Guidewire Software Inc.

      144 - Guidewire Software, Inc. (0001528396) (Subject)

      6/24/25 3:57:14 PM ET
      $GWRE
      Computer Software: Prepackaged Software
      Technology

    $APO
    $ARWR
    $B
    $GWRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Guidewire Software downgraded by DA Davidson with a new price target

      DA Davidson downgraded Guidewire Software from Buy to Neutral and set a new price target of $226.00

      5/22/25 8:20:12 AM ET
      $GWRE
      Computer Software: Prepackaged Software
      Technology
    • Raymond James initiated coverage on Apollo Global Management with a new price target

      Raymond James initiated coverage of Apollo Global Management with a rating of Strong Buy and set a new price target of $173.00

      4/10/25 12:40:27 PM ET
      $APO
      Investment Managers
      Finance
    • BofA Securities resumed coverage on S&P Global with a new price target

      BofA Securities resumed coverage of S&P Global with a rating of Buy and set a new price target of $600.00

      4/10/25 8:19:38 AM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $APO
    $ARWR
    $B
    $GWRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Arrowhead Pharmaceuticals Earns $100 Million Milestone from Sarepta Therapeutics

      - Milestone earned upon reaching first enrollment target in a Phase 1/2 study of ARO-DM1 for the treatment of type 1 myotonic dystrophy Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it has earned a $100 million milestone payment from Sarepta Therapeutics (NASDAQ:SRPT). The milestone was triggered when Arrowhead reached the first of two prespecified enrollment targets and subsequent authorization to dose escalate in a Phase 1/2 clinical study of ARO-DM1, an investigational RNA interference (RNAi) therapeutic for the treatment of type 1 myotonic dystrophy (DM1), the most common adult-onset muscular dystrophy. Arrowhead currently expects to achieve the second enrollment

      7/28/25 7:30:00 AM ET
      $ARWR
      $SRPT
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Veracyte Set to Join S&P SmallCap 600

      NEW YORK, July 24, 2025 /PRNewswire/ -- Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE:TGI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 29. Warburg Pincus LLC and Berkshire Partners LLC will acquire Triumph Group in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector July 29, 2025 S&P SmallCap 600 Addition Veracyte VCYT Health Care July 29, 2025 S&P SmallCap 600 Deletion Triumph Group TGI Industrials For more information about S&P Dow Jones Indices,

      7/24/25 5:58:00 PM ET
      $SPGI
      $TGI
      $VCYT
      Finance: Consumer Services
      Finance
      Aerospace
      Industrials
    • Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

      Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that as an inducement to entering into employment with the Company, on July 22, 2025, the Company's Board of Directors approved "inducement" grants to 38 new employees under Rule 5635(c)(4) of the NASDAQ Listing Rules. The grants entitle employees, in aggregate, to receive up to 52,680 restricted stock units. The grants are outside the Company's stockholder-approved equity incentive plans and vest annually over four years. About Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient

      7/24/25 4:30:00 PM ET
      $ARWR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $APO
    $ARWR
    $B
    $GWRE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Jacoby Rebecca bought $8,971 worth of shares (69 units at $130.01), increasing direct ownership by 17% to 469 units (SEC Form 4)

      4 - S&P Global Inc. (0000064040) (Issuer)

      6/17/24 4:04:40 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • Lu Hongbo bought $82,990 worth of shares (3,000 units at $27.66), increasing direct ownership by 10% to 33,680 units (SEC Form 4)

      4 - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Issuer)

      3/20/24 7:06:58 PM ET
      $ARWR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Mangum Mylle H bought $1,912 worth of shares (67 units at $28.65), increasing direct ownership by 0.25% to 26,367 units (SEC Form 4)

      4 - BARNES GROUP INC (0000009984) (Issuer)

      12/12/23 3:48:02 PM ET
      $B
      Precious Metals
      Basic Materials

    $APO
    $ARWR
    $B
    $GWRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Arrowhead Pharmaceuticals Inc.

      SC 13G - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Subject)

      11/14/24 9:38:25 AM ET
      $ARWR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Arrowhead Pharmaceuticals Inc.

      SC 13G/A - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Subject)

      10/16/24 9:15:20 AM ET
      $ARWR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Guidewire Software Inc.

      SC 13G/A - Guidewire Software, Inc. (0001528396) (Subject)

      7/10/24 1:14:41 PM ET
      $GWRE
      Computer Software: Prepackaged Software
      Technology

    $APO
    $ARWR
    $B
    $GWRE
    Financials

    Live finance-specific insights

    See more
    • Arrowhead Pharmaceuticals to Webcast Fiscal 2025 Third Quarter Results

      Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it will host a webcast and conference call on August 7, 2025, at 4:30 p.m. ET to discuss its financial results for the fiscal 2025 third quarter ended June 30, 2025. Webcast and Conference Call and Details Investors may access a live audio webcast on the Events and Presentations page under the Investors section of the Arrowhead website. A replay of the webcast will be available approximately two hours after the conclusion of the call. For analysts that wish to participate in the conference call, please register at https://register-conf.media-server.com/register/BI3955ca6732974874b0bc0ac323811a7f. Once registered, you w

      7/21/25 4:01:00 PM ET
      $ARWR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • S&P Dow Jones Indices to Acquire ARC Research, Expanding Wealth Data and Benchmarking Capabilities

      LONDON, July 21, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI"), a division of S&P Global (NYSE:SPGI) and the world's leading index provider, today announced that it has entered into a definitive agreement to acquire ARC Research, a subsidiary of ARC Group, and the leading independent provider of investment performance data, benchmarking capabilities and insights in the private wealth market. ARC Research maintains the world's largest proprietary dataset of more than 500,000 private client portfolios spanning over two decades. The firm is a trusted partner to more than

      7/21/25 7:00:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • Barrick to Report Second Quarter 2025 Results on August 11, 2025

      TORONTO, July 17, 2025 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) will release its second quarter 2025 results before markets open on Monday, August 11, 2025 at approximately 6:00 AM EDT. President and CEO Mark Bristow will host a webcast to discuss the results at 11:00 AM EDT followed by a question-and-answer session with analysts. Q2 2025 RESULTSQ2 Results releaseAugust 11, 06:00 EDT / 10:00 UTCLive presentation and webcastAugust 11, 11:00 EDT / 15:00 UTCRegister to attend the webcast The presentation materials will be available on Barrick's website at www.barrick.com and the webinar will remain online for later viewing. About Barrick Mining Corporation Barrick is

      7/17/25 7:00:00 AM ET
      $B
      Precious Metals
      Basic Materials

    $APO
    $ARWR
    $B
    $GWRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Veracyte Set to Join S&P SmallCap 600

      NEW YORK, July 24, 2025 /PRNewswire/ -- Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE:TGI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 29. Warburg Pincus LLC and Berkshire Partners LLC will acquire Triumph Group in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector July 29, 2025 S&P SmallCap 600 Addition Veracyte VCYT Health Care July 29, 2025 S&P SmallCap 600 Deletion Triumph Group TGI Industrials For more information about S&P Dow Jones Indices,

      7/24/25 5:58:00 PM ET
      $SPGI
      $TGI
      $VCYT
      Finance: Consumer Services
      Finance
      Aerospace
      Industrials
    • Block Set to Join S&P 500

      NEW YORK, July 18, 2025 /PRNewswire/ -- Block Inc. (NYSE:XYZ) will replace Hess Corp. (NYSE:HES) in the S&P 500 effective prior to the opening of trading on Wednesday, July 23. S&P 500 and S&P 100 constituent Chevron Corp. (NYSE: CVX) has acquired Hess Corp in a deal that closed today, July 18. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name  Action Company Name Ticker GICS Sector July 23, 2025 S&P 500 Addition Block XYZ Financials July 23, 2025 S&P 500 Deletion Hess HES Energy For more information about S&P Dow Jones Indices, please visit www.spdji.com.  ABOUT S&P DOW JONES INDICES S&P Dow Jones Indi

      7/18/25 6:02:00 PM ET
      $CVX
      $HES
      $SPGI
      $XYZ
      Integrated oil Companies
      Energy
      Finance: Consumer Services
      Finance
    • Finzly Appoints First Chief Financial Officer and Head of Partnerships to Accelerate Growth and Expand Market Reach

      Highly experienced industry veterans Adam Carson, CFO and Robert Coakley, Head of Partnerships join executive team CHARLOTTE, N.C., July 17, 2025 /PRNewswire/ -- Finzly, a leading provider of modern payment infrastructure for financial institutions, today announced the appointment of Adam Carson as its first Chief Financial Officer and Robert Coakley as Head of Partnerships. These strategic additions come as Finzly continues to scale its operations and expand market reach amid growing demand for its payment modernization solutions. Carson brings 20 years of experience delivering growth and scale in software and technology companies. As CFO of Cyence, he helped navigate the company's acquisi

      7/17/25 8:00:00 AM ET
      $GWRE
      Computer Software: Prepackaged Software
      Technology